For decades, the only legitimate route to a hearing aid in the U.S. ran through an audiologist's office. That changed on October 17, 2022, when the FDA's final rule on over-the-counter hearing aids took effect — creating a regulated retail category for adults 18 and over with perceived mild-to-moderate hearing loss. The change was the most significant consumer reform in hearing care in a generation.

Three years in, the question for most adults is no longer whether OTC hearing aids are legitimate; it is whether they are the right starting point for them, or whether prescription is the better path. The answer depends on five factors: who you are, how complicated your hearing is, how much follow-up care you want, what you can spend, and how comfortable you are with self-service technology.

What the FDA rule actually changed

Before the rule, all hearing aids in the U.S. required a medical evaluation or a written waiver, and most states layered on additional dispensing requirements. The new rule creates two regulated categories:

  • OTC hearing aids — for adults 18+ with perceived mild-to-moderate hearing loss. Sold directly to consumers, in stores or online, without a hearing exam.
  • Prescription hearing aids — for adults with more significant loss, complex hearing histories, or any pediatric case. Dispensed by a licensed audiologist or hearing aid specialist.

OTC devices are still FDA-regulated medical devices. They must meet output limits, electroacoustic performance requirements, and labeling rules — including a clear "OTC" designation and warnings about when to see a professional. They are not the same thing as unregulated "personal sound amplification products" (PSAPs).

The practical differences

Fitting

A prescription fitting starts with a full audiogram performed by an audiologist in a sound-treated booth, often supplemented by speech-in-noise testing and real-ear measurement — a probe-microphone measurement that verifies how the device actually performs inside the wearer's ear canal. The audiologist programs the device, adjusts the fit over several visits, and educates the wearer on use and care.

An OTC fitting, for the self-fitting category, runs through an in-app hearing test in a quiet room. The device sets its own amplification curve, and the wearer fine-tunes through the app. This is a real fitting process — the FDA's self-fitting designation has specific requirements — but it is not equivalent to a clinic fit, particularly for asymmetric, sloping, or complex loss.

Follow-up care

Prescription hearing aids typically come bundled with follow-up appointments for at least the first year: adjustments, cleaning, real-ear re-measurement, and counseling on how to integrate the devices into daily life. Many adults find this hand-holding genuinely useful, particularly for their first pair.

OTC hearing aids generally do not include in-person follow-up. Most reputable sellers offer phone or video support, and some offer scheduled calls with hearing professionals. This is sufficient for many wearers but not all — especially for adults who would benefit from a clinician's hand on the device.

Cost

This is the area where OTC has had the largest immediate impact. Prescription hearing aids in the U.S. typically cost between $2,500 and $6,000 per pair when bundled with professional services, and Medicare does not generally cover them. OTC hearing aids in 2026 range from roughly $200 for entry-level preset amplifiers to about $2,500 for premium self-fitting devices — with most serious OTC devices priced between $800 and $1,500 per pair.

Some employers, Medicare Advantage plans, and FSA/HSA programs now cover OTC purchases; coverage varies, and the rules are worth checking before buying.

Daily life

For day-to-day use, modern OTC and prescription hearing aids have converged more than most consumers realize. Both categories offer rechargeable models, Bluetooth phone streaming, environment programs, and app-based control. The hardware gap that existed a decade ago is much narrower today; the gaps that remain are around fit precision, the most complex hearing profiles, and the depth of personalization a clinician can perform.

Who OTC hearing aids are for

OTC is a reasonable starting point if most of the following are true:

  • You are 18 or older.
  • Your hearing loss has been gradual, over years.
  • Both ears are affected similarly.
  • Your main complaint is following conversation in noisy rooms.
  • You are comfortable with a smartphone and a setup app, or you are buying a preset device with no app dependency.
  • The seller offers a 45-day risk-free trial and a 1-year warranty at minimum.

Who should start with prescription

A clinician-fit device is the safer path if any of the following apply:

  • Your hearing loss came on suddenly — over days or weeks rather than years.
  • One ear is meaningfully worse than the other.
  • You have ear pain, drainage, or persistent tinnitus.
  • You experience dizziness or balance issues.
  • Your hearing loss appeared after a head injury, infection, or ototoxic medication.
  • You are under 18, or you are buying for a child.
  • You have a history of ear surgery or middle-ear conditions.
  • You have tried OTC and find that even at meaningful amplification it does not help.

In several of these scenarios, the medical question matters more than the device question. A clinician can rule out treatable causes — from earwax impaction to middle-ear conditions to acoustic neuroma — that no consumer device can detect.

OTC and PSAPs are not the same thing. Personal sound amplification products (PSAPs) are unregulated consumer-electronics devices that boost ambient sound for people without hearing loss — the bird-watching crowd is the canonical use case. They are not hearing aids, are not FDA-regulated as medical devices, and are not designed to address hearing loss. Treat any product that markets itself as a hearing aid but is labeled a "PSAP" with skepticism.

A hybrid path that often works

Some adults benefit from combining the two routes. A common pattern in 2026 looks like this: have a baseline audiogram done by an audiologist (often the same out-of-pocket cost as a flu shot at many clinics), then make an informed decision between OTC and prescription with that audiogram in hand. If you go OTC, the audiogram tells you whether your loss is genuinely mild-to-moderate. If you go prescription, you have a baseline for fitting.

This hybrid path captures most of the cost benefit of OTC while keeping a clinician involved at the diagnostic step where it matters most.

What to ask before you buy — either way

Regardless of which category you choose, the buyer's checklist is similar:

  • What is the trial period, and are there restocking fees?
  • How long is the warranty, and what does it cover?
  • What support is included — phone, video, in-person?
  • What is the cost of follow-up adjustments, if needed?
  • How is hardware repaired or replaced if it fails?
  • Is the device the right form factor for your ear and your dexterity?

The bottom line

OTC and prescription hearing aids are two regulated paths into the same end goal — better hearing in daily life. Neither is universally better. For a 65-year-old with gradual, symmetric loss who lives in a noisy city and is comfortable with a smartphone, OTC is often the most efficient starting point. For an 80-year-old whose loss is uneven, who has tinnitus, or who would benefit from a clinician's hand on the device, prescription remains the right path.

The most important step, in either case, is honest evaluation of where the buyer actually sits on the spectrum — not the category that happens to be in the news.

References

  1. U.S. Food & Drug Administration. Final rule on over-the-counter hearing aids (effective October 17, 2022).
  2. National Institute on Deafness and Other Communication Disorders (NIDCD). "Quick Statistics About Hearing" and "Hearing Aids."
  3. U.S. Federal Trade Commission. Consumer guidance on hearing aid advertising and PSAP labeling.
  4. World Health Organization. World Report on Hearing, 2021.
  5. JAMA Otolaryngology and JAMA Internal Medicine reports on OTC hearing aid adoption and outcomes, 2022–2024.
  6. American Academy of Audiology and American Speech-Language-Hearing Association position statements on OTC hearing aids.